BBA
IMCR icon

Baker Bros. Advisors’s Immunocore IMCR Stock Holding History

Baker Bros. Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-734,397
Closed -$22.1M – 89
2026
Q1 		$22.1M Sell
734,397
-1,588,259
-68% -$51.4M 0.13% 49
2025
Q4 		$80.6M Hold
2,322,656
– – 0.47% 29
2025
Q3 		$84.4M Hold
2,322,656
– – 0.61% 21
2025
Q2 		$72.9M Hold
2,322,656
– – 0.71% 19
2025
Q1 		$68.9M Buy
2,322,656
+807,338
+53% +$24.2M 0.76% 16
2024
Q4 		$44.7M Hold
1,515,318
– – 0.48% 26
2024
Q3 		$47.2M Hold
1,515,318
– – 0.49% 25
2024
Q2 		$51.4M Hold
1,515,318
– – 0.66% 24
2024
Q1 		$98.5M Sell
1,515,318
-1,005,413
-40% -$69M 1.24% 11
2023
Q4 		$172M Hold
2,520,731
– – 1.96% 7
2023
Q3 		$131M Hold
2,520,731
– – 0.75% 9
2023
Q2 		$151M Hold
2,520,731
– – 0.87% 7
2023
Q1 		$125M Hold
2,520,731
– – 0.68% 7
2022
Q4 		$144M Hold
2,520,731
– – 0.86% 10
2022
Q3 		$118M Buy
2,520,731
+1
+0% +$48 0.77% 11
2022
Q2 		$94M Hold
2,520,730
– – 0.53% 14
2022
Q1 		$75.4M Hold
2,520,730
– – 0.43% 19
2021
Q4 		$86.3M Hold
2,520,730
– – 0.42% 21
2021
Q3 		$93.4M Hold
2,520,730
– – 0.41% 20
2021
Q2 		$98.4M Hold
2,520,730
– – 0.43% 21
2021
Q1 		$107M Buy
+2,520,730
New +$112M 0.47% 19

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Baker Bros. Advisors's IMCR Position: Q2 2026 in Review

Baker Bros. Advisors sold out of Immunocore (IMCR) in Q2 2026, closing a stake of 734,397 shares — an estimated $22.1M sold.

Baker Bros. Advisors first reported a position in IMCR in Q1 2021 and held it in 21 quarters. The position peaked at $172M in Q4 2023. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Baker Bros. Advisors reported no remaining Immunocore position as of Q2 2026 after selling out during the quarter.
  • Baker Bros. Advisors sold 734,397 Immunocore shares in Q2 2026, an estimated $22.1M.
  • Baker Bros. Advisors first reported a position in Immunocore in Q1 2021 and held it in 21 quarters.
  • Baker Bros. Advisors's Immunocore position peaked at $172M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.